Introduction
============

Since first introduced in the late 1990s, liquid-based cytology (LBC) was quickly adopted by many laboratories as a great improvement in the performance of gynaecologic cytology. The method permits laboratories to create slides rather than having prepared slides sent to them in various degrees of fixation and preparation. The LBC methodology also provides a cleaner smear as the proprietary methods remove obscuring elements such as blood and inflammation. This 'cleaning' of samples is often cited as the reason there are lower unsatisfactory rates in LBC.[@b1] The liquid platforms also allow for reflex testing for human papilloma virus for borderline cases. However, large trials and a meta-analysis have recently shown that the performance of LBC may be equivalent to conventional cytology, thus making it difficult for laboratories to justify the added expense of LBC.[@b2; @b3; @b4]

When considering LBC, laboratories are faced with a decision between two main platforms produced by ThinPrep (Hologic) and SurePath (Becton Dickinson). Both technologies are Food and Drug Administration approved but employ different methodologies in sample preparation. In light of these differences in preparation, we set out to evaluate the existing English literature comparing the performance of each platform with respect to unsatisfactory rates.

Methods
=======

Information sources and search strategy
---------------------------------------

Our meta-analysis adhered to the PRISMA statement for reporting on meta-analyses.[@b5] The initial literature search for articles was conducted using PubMed. Articles published in English between 1 January 1990 and 1 August 2011 were retrieved using the search words 'unsatisfactory' and 'ThinPrep or SurePath'. These date range were chosen to coincide with the period following the introduction of The Bethesda System (TBS) in 1989.[@b6] The references of the retrieved papers were examined for further possible studies not detected in the initial literature search. Additionally, we searched major clinical trial registries (<http://clinicaltrials.gov>, <http://isrctn.org>, <http://www.umin.ac.jp/ctr/index/htm/>, <http://www.anzctr.org.au/Default.aspx>, <http://www.trialregister.nl/trialreg/index.asp>, <http://apps.who.int/trialsearch>) using the search words 'liquid-based cytology', contacted both manufacturers and contacted key researchers in the field to check for ongoing or unpublished studies.

Study selection and eligibility criteria
----------------------------------------

Eligible studies for the review presented rates of technically unsatisfactory cervical cytology smears performed on either ThinPrep or SurePath platform. For inclusion in the meta-analysis, studies must have presented data on unsatisfactory cervical cytology smears performed on both ThinPrep and SurePath platforms by the same laboratory on the same patient population. Only studies presented in English were considered. Both published and unpublished studies were considered to be eligible for inclusion.

The initial search retrieved 76 papers. The abstracts of these papers were reviewed by CN and DF and 46 were chosen for full review. An additional six published studies were subsequently identified as well as one unpublished study. Of these articles, 42 met the further inclusion criteria of presenting data on unsatisfactory rates for either ThinPrep or SurePath and utilising actual patient samples (ie, not laboratory manipulated samples) and not employing glacial acetic acid to increase the satisfactory rate. Four of these studies presented data on both ThinPrep and SurePath use in the same population by the same laboratory and were therefore included in the meta-analysis. Our contacts with industry and other researchers did not reveal additional usable studies. The selection process is summarised in [figure 1](#fig1){ref-type="fig"}.
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Data extraction
---------------

Two of the authors (CN and DF) extracted data independently from the 42 studies meeting the inclusion criteria. These results were then compared and any discrepancies resolved. The following data were extracted: (1) number of patients included, (2) type of liquid-based system used (ThinPrep or SurePath), (3) per cent of unsatisfactory cases, (4) country of study, (5) year of study, (6) whether image analysis software was used to screen the slides and (7) the number of women in the study (sample size). The lack of ambiguity of the outcome measure (only two end points are possible: unsatisfactory or satisfactory), combined with the irrelevance of a follow-up (latent) period, obviated the need for quality scoring of the included studies.

Statistical analysis
--------------------

Unsatisfactory rates were first compared using a univariate general linear model in SPSS V.19. The dependent variable was unsatisfactory rate, and the dependent variables were year of study (divided into 2002 and before to capture studies published before TBS revision in 2001 and 2003 and later), platform (ThinPrep vs SurePath), country where study was performed and whether image analysis software was used. Studies were weighted by the number of women participating in each one. In addition to the significance level, observed power was calculated for each variable. Differences were considered significant at an α level of 0.05. Meta-analysis was then performed using Review Manager V.4.2.[@b7] A χ^2^ test for heterogeneity among studies included in the meta-analysis revealed an I^2^ of 97% with a p value of \<0.00001, indicating significant heterogeneity among these studies (although the heterogeneity was quantitative rather than qualitative as all the trials demonstrated the same trend). Therefore, a random effects model was employed to calculate the pooled OR.

Results
=======

A total of 1 120 418 cervical cytology smears were reported in 14 different studies using the SurePath platform ([table 1](#tbl1){ref-type="table"}). The pooled unsatisfactory rate (weighted average) was 0.3%. For cervical cytology smears processed on the ThinPrep platform, 28 studies reported on 1 148 755 smears for a pooled unsatisfactory rate (weighted average) of 1.3% ([table 2](#tbl2){ref-type="table"}). A general linear model as previously described was employed to test for a difference in unsatisfactory rate ThinPrep and SurePath. Year of publication (p=0.021) and country where research was performed (p=0.004) were independent predictors of unsatisfactory rate. The use of image analysis software (p=0.091) and the LBP platform used (p=0.558) were not independent predictors of unsatisfactory rate. However, the observed power for LBP platform was very low at 0.087, making the risk of a type II error high. To attempt to gain statistical power, we performed a meta-analysis where we considered only studies where both platforms were evaluated on the same patient population by the same laboratory. We found three such studies in the published literature and added data from one additional unpublished study ([table 3](#tbl3){ref-type="table"}). All four of these studies reported similar populations but different patients who were screened with either ThinPrep or SurePath platform. The pooled RR from the meta-analysis was 0.44 (95% CI 0.25 to 0.77) in favour of SurePath over ThinPrep ([figure 2](#fig2){ref-type="fig"}). A Z-test for overall effect was statistically significant at p=0.004.

###### 

Unsatisfactory cervical cytology smear rates in populations using the SurePath platform

  Lead author                   Year          Total number of cervical cytology smears   Number of unsatisfactory smears   Percentage of unsatisfactory smears   Location of study
  ----------------------------- ------------- ------------------------------------------ --------------------------------- ------------------------------------- -------------------
  Colgan *et al*[@b8]           2004          352 680                                    915                               0.3                                   Canada
  Zhao *et al*[@b9]             2011          972                                        2                                 0.2                                   China
  Kirscher *et al*[@b10]        2006          84 414                                     292                               0.3                                   Denmark
  Beerman *et al*[@b11]         2008          35 315                                     46                                0.1                                   the Netherlands
  Sykes *et al*[@b12]           2008          451                                        12                                2.7                                   New Zealand
  Sykes *et al*[@b12]           2008          457                                        12                                2.6                                   New Zealand
  Kitchener *et al*[@b13]       2011          22 145                                     354                               1.6                                   UK
  Narine and Young[@b14]        2007          53 982                                     208                               0.4                                   UK
  Narine and Young[@b14]        Unpublished   27 738                                     327                               1.2                                   UK
  Alsharif *et al*[@b15]        2009          232 022                                    360                               0.2                                   USA
  Stark[@b16]                   2007          137 703                                    302                               0.2                                   USA
  Nance[@b17]                   2007          92 875                                     158                               0.2                                   USA
  Fremont-Smith *et al*[@b18]   2004          58 580                                     130                               0.2                                   USA
  Sass[@b19]                    2003          8771                                       14                                0.2                                   USA
  Wilbur *et al*[@b20]          2009          12 313                                     27                                0.2                                   USA
  Total                                       1 120 418                                  3159                              0.3                                   

###### 

Unsatisfactory cervical cytology smear rates in populations using the ThinPrep platform

  Lead author                Year          Total number of cervical cytology smears   Number of unsatisfactory smears   Percentage of unsatisfactory smears   Location of study
  -------------------------- ------------- ------------------------------------------ --------------------------------- ------------------------------------- -------------------
  Davey *et al*[@b21]        2007          52 665                                     795                               1.5                                   Australia
  Roberts *et al*[@b22]      1997          35 560                                     235                               0.7                                   Australia
  Shield *et al*[@b23]       1999          300                                        19                                6.3                                   Australia
  Halford *et al*[@b24]      2009          87 284                                     758                               0.9                                   Australia
  Duggan *et al*[@b25]       2006          2288                                       10                                0.4                                   Canada
  Belison *et al*[@b26]      2002          1450                                       158                               10.9                                  China
  Zhao *et al*[@b9]          2011          1033                                       15                                1.5                                   China
  Yeoh *et al*[@b27]         1999          16 541                                     93                                0.6                                   Hong Kong
  Cheung *et al*[@b28]       2003          190 667                                    608                               0.3                                   Hong Kong
  Grace *et al*[@b29]        2002          1000                                       13                                1.3                                   Ireland
  Treacy *et al*[@b1]        2009          41 312                                     1342                              3.2                                   Ireland
  Ronco *et al*[@b30]        2007          22 708                                     583                               2.6                                   Italy
  Rahimi *et al*[@b31]       2008          467                                        9                                 1.9                                   Italy
  Luthra *et al*[@b32]       2001          1024                                       36                                3.5                                   Kuwait
  Siebers *et al*[@b33]      2008          46 064                                     153                               0.3                                   the Netherlands
  Williams[@b34]             2006          78 064                                     1493                              1.9                                   Scotland
  Taylor *et al*[@b35]       2006          3184                                       70                                2.2                                   South Africa
  Tuncer *et al*[@b36]       2005          4322                                       72                                1.7                                   Turkey
  Kitchener *et al*[@b13]    2011          23 436                                     456                               1.9                                   UK
  Narine and Young[@b14]     Unpublished   58 973                                     1250                              2.1                                   UK
  Alsharif *et al*[@b15]     2009          5419                                       124                               2.3                                   USA
  Nance[@b17]                2007          88 575                                     567                               0.6                                   USA
  Bentz[@b37]                2002          23 790                                     209                               0.9                                   USA
  Bentz[@b37]                2002          15 154                                     197                               1.3                                   USA
  Bolick and Hellman[@b38]   1998          10 694                                     31                                0.3                                   USA
  Wachtel *et al*[@b39]      2009          2890                                       77                                2.7                                   USA
  Harkness *et al*[@b40]     2003          3000                                       80                                2.7                                   USA
  Duby and DiFurio[@b41]     2009          55 438                                     1027                              1.8                                   USA
  Duby and DiFurio[@b41]     2009          53 209                                     783                               1.5                                   USA
  Zhao and Austin[@b42]      2009          222 242                                    3230                              1.4                                   USA
  Total                                    1 148 755                                  15 593                            1.3                                   

###### 

Studies included in the meta-analysis

  Lead author               Year          Platform   Total number of cervical cytology smears   Number of unsatisfactory smears   Percentage of unsatisfactory smears   Location of study
  ------------------------- ------------- ---------- ------------------------------------------ --------------------------------- ------------------------------------- -------------------
  Zhao *et al*[@b9]         2011          TP         972                                        2                                 1.5                                   China
  Zhao *et al*[@b9]         2011          SP         1033                                       15                                0.2                                   China
  Kitchener *et al*[@b13]   2011          TP         23 436                                     456                               2.0                                   UK
  Kitchener *et al*[@b13]   2011          SP         22 145                                     354                               1.6                                   UK
  Narine and Young[@b14]    Unpublished   TP         58 973                                     1250                              2.1                                   UK
  Narine and Young[@b14]    Unpublished   SP         27 738                                     327                               1.2                                   UK
  Nance[@b17]               2007          TP         88 575                                     567                               0.6                                   USA
  Nance[@b17]               2007          SP         92 875                                     158                               0.2                                   USA

SP, SurePath; TP, ThinPrep.
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Because of the small number of studies included in the meta-analysis, a funnel plot was not informative. However, the four included showed similar unsatisfactory rates to other studies and therefore we felt were representative of the other studies retrieved.

Discussion
==========

Despite being one of the most successful screening tests for cancer, cervical cytology smears have been criticised for low sensitivity. False-negative cervical cytology smears are responsible for this decrease in sensitivity and may result from collection errors, screening errors or interpretation errors.

We set out to examine unsatisfactory rates in LBC as these have been demonstrated to be largely reproducible within laboratories but not across laboratories.[@b43] Most laboratories use TBS or some modification thereof for interpretation of cervical cytology smears. We could not, however, establish the criteria used to determine adequacy for each platform; some laboratories use the methods described in the manufacturer\'s guide (TBS based), while others have adopted their own criteria and many authors do not elaborate on this in their methods. Furthermore, our results showed that year of publication and to a greater extent country were significant confounding factors in the comparison of unsatisfactory rates between ThinPrep and SurePath platforms. These confounding factors resulted in very low power to detect a statistically significant difference in unsatisfactory rates, despite a wide difference in mean unsatisfactory rates between the two platforms. In contrast, a meta-analysis comparing four head-to-head studies did reveal a lower unsatisfactory rate for the SurePath platform. These differences underscore the fact that multiple factors are associated with overall unsatisfactory rates with the platform used representing only one of these.

It is also acknowledged that there are other possible biases in the source literature that our analyses could not control for. These include the relative experience of the cytologists in reading slides prepared using one or the other platform and any possible undisclosed biases in the allocation of individuals to treatment groups in the four head-to-head studies. The differences in unsatisfactory rates due to LBC platform we report here are most likely a function of differences in the proprietary methodology for each platform. ThinPrep employs a filter-based technology, while SurePath uses a density/sedimentation process. Differences are also encountered when collecting the sample; ThinPrep requires the collector to rinse the collection device in the liquid media that is followed by disposal of the collection device. In contrast, the SurePath collection device is placed in the media and sent to the laboratory for processing. This difference has been demonstrated to account for up to 38% loss of the ThinPrep sample in a study by Bigras *et al*.[@b44] These preparatory differences represent a significant technical difference, which laboratories must consider prior to adopting LBC. However, counterbalancing this loss of sample is the fact that ThinPrep samples are significantly less labour intensive than SurePath samples for the processing laboratory.

As [tables 1](#tbl1){ref-type="table"} and [2](#tbl2){ref-type="table"} show, there was considerable variation in unsatisfactory rates among jurisdictions, with countries in the European Union in particular tending to show higher unsatisfactory rates in both studies of SurePath and ThinPrep. This is likely attributable to variations in adequacy criteria compared with TBS.

Both the SurePath (FocalPoint GS) and ThinPrep (ThinPrep Imager) systems include optional computer-assisted digital image analysis software. If we examine only studies using this technology, three studies using the ThinPrep Imager all gave unsatisfactory rates of 1.5%[@b21] [@b41] [@b42]---similar to other ThinPrep studies included in this review. The single study evaluating the FocalPoint GS system showed an unsatisfactory rate of 0.2%,[@b19] again similar to the other SurePath studies reviewed.

Reprocessing of unsatisfactory ThinPrep slides using glacial acetic acid can decrease the unsatisfactory rates by 30%--40%.[@b45] However, use of this technique still would not result in equivalency with SurePath unsatisfactory rates and introduces additional issues including a higher false-positive rate[@b46] and interferes with the ability to perform hybrid capture human papilloma virus testing.[@b47]

The data presented here show a significant difference between the different platforms with SurePath having a significantly lower rate of unsatisfactory samples. This pattern was observed when considering different countries and methods used to determine thresholds for unsatisfactory designation. Consistent with this observation are data from a College of American Pathologist survey reporting differences in unsatisfactory rates between laboratories using SurePath (median unsatisfactory rate 0.3%) and ThinPrep (median unsatisfactory rate 1.1%) platforms.[@b48] These numbers are similar to the pooled unsatisfactory rates we report in this study (0.3% for SurePath and 1.3% for ThinPrep).

A limitation of our study is that it considers only one aspect of LBP platform selection (unsatisfactory rate), whereas other factors such as specificity and sensitivity must also be considered. A discussion of this is outside the scope of this paper but interested readers are referred to the meta-analysis of Arbyn *et al*[@b4] for further information. The implication of this unsatisfactory rate difference is also a consideration for specimens, which could be biobanked for further studies to evaluate new biomarkers and how they may perform in unsatisfactory LBC samples.[@b49]

Unsatisfactory samples represent a missed opportunity for screening[@b50] and are more often associated with a cervical abnormality.[@b51] It has also been well described that patients with an invasive cervical cancer have a much greater rate of unsatisfactory Pap smears, often as a result of scant cellularity and obscuring elements such as blood and inflammation.[@b52; @b53; @b54] In addition to the technical requirements of sample preparation, laboratories may wish to consider the variation in unsatisfactory sample rates when choosing an LBC platform.
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